JF Rossi
- Hematology top 2%
- Multiple Myeloma Research and Treatments 8
- Hematopoietic Stem Cell Transplantation 5
- Oncology top 5%
- Cytokine Signaling Pathways and Interactions 4
- Chemokine receptors and signaling 3
- Immunology top 10%
- Immune Cell Function and Interaction 3
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research 3
-
- Lymphoma Diagnosis and Treatment 4
-
- Monoclonal and Polyclonal Antibodies Research 3
- Co-authors
- Bernard KleinRégis BatailleLu ZyJ BrochierJohn WijdenesZY LuTim N. BeckThierry Lavabre‐Bertrand
- Cited by
- HematologyOncologyImmunology
- Partner nations
- FranceNetherlandsUnited Kingdom
In The Last Decade
JF Rossi
22 papers receiving 895 citations
Peers
Comparison fields: 5 of 59
- Hematology 461
- Oncology 473
- Immunology 319
- Genetics 99
- Pathology and Forensic Medicine 113
Countries citing papers authored by JF Rossi
This map shows the geographic impact of JF Rossi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JF Rossi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JF Rossi more than expected).
Fields of papers citing papers by JF Rossi
This network shows the impact of papers produced by JF Rossi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JF Rossi. The network helps show where JF Rossi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside JF Rossi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 9 | |
| 2 | 2010 | 152 | |
| 3 | 2006 | 10 | |
| 4 | 2001 | 25 | |
| 5 | 2001 | 31 | |
| 6 | 1999 | 9 | |
| 7 | IFN-alpha is a survival factor for human myeloma cells and reduces dexamethasone-induced apoptosis. | 1998 | 49 |
| 8 | [Role of ceftriaxone in febrile neutropenia]. | 1997 | 1 |
| 9 | 1996 | 95 | |
| 10 | 1995 | 207 | |
| 11 | 1995 | 105 | |
| 12 | 1995 | 5 | |
| 13 | 1995 | 81 | |
| 14 | 1992 | 9 | |
| 15 | 1992 | 34 | |
| 16 | Maintenance treatment with recombinant alpha interferon after autologous bone marrow transplantation for aggressive myeloma in first remission after conventional induction chemotherapy. | 1991 | 18 |
| 17 | Allogeneic or autologous bone marrow transplantation for acute lymphoblastic leukemia in first complete remission. | 1990 | 56 |
| 18 | 1985 | 1 | |
| 19 | 1985 | 14 | |
| 20 | [Hereditary osteo-onychodysplasia. Histomorphometric bone study. Apropos of a case]. | 1983 | 2 |
About JF Rossi
JF Rossi is a scholar working on Hematology, Oncology, Immunology, Transplantation and Genetics, having authored 22 papers that have together received 927 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (8 papers), Hematopoietic Stem Cell Transplantation (5 papers), Lymphoma Diagnosis and Treatment (4 papers), Cytokine Signaling Pathways and Interactions (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), Chemokine receptors and signaling (3 papers), Immune Cell Function and Interaction (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). The work is most often cited by research in Hematology (461 citations), Oncology (473 citations), Immunology (319 citations), Genetics (99 citations) and Pathology and Forensic Medicine (113 citations). JF Rossi has collaborated with scholars based in France, Netherlands and United Kingdom. Frequent co-authors include Bernard Klein, Régis Bataille, Lu Zy, J Brochier, John Wijdenes, ZY Lu, Tim N. Beck, Thierry Lavabre‐Bertrand, Bart Barlogie and R Bataille. Their work appears in journals such as Blood, Bone Marrow Transplantation, Leukemia, British Journal of Cancer and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.